CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors
- 1 February 2005
- journal article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 33 (1) , 311-315
- https://doi.org/10.1042/bst0330311
Abstract
CD36 is an important regulator of lipid metabolism in vivo due to its role in the facilitated uptake of long-chain FAs (fatty acids). CD36-deficient mice display reduced TAG (triacylglycerol) in muscle, but elevated hepatic TAG. Also, insulin sensitivity is enhanced peripherally, while it appears impaired in the liver. Tissues such as muscle, which normally express high levels of CD36, shift to high glucose utilization in CD36 deficiency, so we hypothesized that this shift must involve adaptive changes in the PPAR (peroxisome-proliferator-activated receptor) transcription factors which regulate FA metabolism. To test this, we examined mRNA levels for the three PPAR isoforms in tissues of WT (wild-type) and CD36-deficient mice following the administration of saline, glucose or olive oil by intragastric gavage. Compared with WT mice, CD36-null mice had 5-10-fold increased PPAR mRNA in adipose tissue in the basal state, and did not exhibit diet-induced changes. Correlations between adipose PPAR mRNA abundance and plasma lipids were observed in WT mice, but not in CD36-null mice. The opposite was true for hepatic PPAR mRNA levels, which correlated with plasma FA, TAG and/or glucose only in CD36-null mice. No significant differences were observed in PPAR mRNA levels in the intestine, where CD36 does not impact on FA uptake. The data suggest that CD36 and the PPARs are components of the FA-sensing machinery to respond to changes in FA flux in a tissue-specific manner.Keywords
This publication has 26 references indexed in Scilit:
- Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) α and δ and PPAR coactivator 1α in human skeletal muscle, but not lipid regulatory genesJournal of Molecular Endocrinology, 2004
- ThiazolidinedionesNew England Journal of Medicine, 2004
- A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in CaucasiansHuman Molecular Genetics, 2004
- CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in miceJournal of Lipid Research, 2003
- Pharmacogenetic Evidence That Cd36Is a Key Determinant of the Metabolic Effects of PioglitazoneJournal of Biological Chemistry, 2002
- Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout MiceJournal of Biological Chemistry, 2000
- Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in miceJournal of Clinical Investigation, 2000
- Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and Inducer-specific MannerJournal of Biological Chemistry, 1998
- Localization and Regulation of the Putative Membrane Fatty‐Acid Transporter (FAT) in the Small IntestineEuropean Journal of Biochemistry, 1996
- Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: Isolation and ammo-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acidsThe Journal of Membrane Biology, 1993